G. Surdhar

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development.

F. Hill, M. D. Williams, S. Lawson, 2001, Blood.

Cycle sequencing of PCR products.

G. Surdhar, 2002, Methods in molecular biology.

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease.

K. Pasi, F. Hill, M. D. Williams, 2001, Blood.

Inherited and de novo von Willebrand disease ‘Vicenza’ in UK families with the R1205H mutation: diagnostic pitfalls and new insights

P. Collins, F. Hill, A. Cumming, 2006, British journal of haematology.

type 3 von Willebrand disease and predisposition to inhibitor development Homozygous gene conversion in von Willebrand factor gene as a cause of

F. Hill, S. Lawson, M. Williams, 2001 .

A New Candidate Missense Mutation (Leu 1657 Ile) in an Apparently Asymptomatic Type 2A (Phenotype IIA) von Willebrand Disease Family

F. Hill, B. Theophilus, A. Guilliatt, 2000, Thrombosis and Haemostasis.

Use of Intron 40 VNTR I in vWD Gene Tracking.

G. Surdhar, M. Enayat, 1999, Methods in molecular medicine.